Wyss Zurich
Philipp Busenhart is the COO and co-founder of Recolony, where they serve as the Head of Business Development Project Recolony at Wyss Zurich. Prior to their current roles, Philipp worked as a Postdoctoral Researcher at Universität Zürich and completed a traineeship at Novartis Oncology. They hold a PhD in Oncology and Cancer Biology, an MS in Oncology and Cancer Biology, and a BS in Biology from the University of Zurich. Philipp's experience includes developing high-throughput cellular model systems for drug efficacy and testing novel small-molecule compounds for cancer treatments.
This person is not in any teams
Wyss Zurich
Wyss Zurich is a joint research and development center of the University of Zurich and the ETH Zurich, made possible by a generous donation from the Swiss entrepreneur and philanthropist Dr. hc. mult. Hansjörg Wyss. The mission of Wyss Zurich is to drive the clinical translation and technology transfer of outstanding scientific discoveries into new therapies for patients and breakthrough innovations in the emerging fields of Regenerative Medicine, Robotics and Medical Devices/Bionics Technologies. Wyss Zurich brings together some of the world’s leading experts to form multidisciplinary teams, pooling their knowledge and expertise.